Appian APPN 深 沪
等待开盘 05-19 09:30:00 美东时间
20.895
+1.365
+6.99%
华盛通- 最 高20.94
- 今 开19.40
- 成交量 48.70万股
- 最 低 19.32
- 昨 收 19.53
- 总市值 153.39万
- 52周最高 46.059
- 市盈率 静 1266.36
- 换手率 0.66%
- 52周最低 18.63
- 委 比 26.49%
- 总股本 7.34万
- 历史最高 260.00
- 量 比 0.75
- 振 幅 8.29%
- 历史最低 15.229
- 每 手 1
- 风险率 5.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 应用材料获17家大行集体上调目标价；Bitdeer 、Forgent 、嘉信理财、Viking等获多家大行上调目标价
今日重点评级关注：Chardan Capital：维持Senti Biosciences"买入"评级，目标价从11美元升至12美元；Ladenburg Thalmann：维持Usio"买入"评级，目标价从5.75美元升至6.25美元
05-18 11:48
TD Cowen Maintains Hold on Appian, Lowers Price Target to $24
TD Cowen analyst Derrick Wood maintains Appian (NASDAQ:APPN) with a Hold and lowers the price target from $27 to $24.
05-16 01:09
Osisko Development Reports First Quarter 2026 Results
Osisko Development Corp. reported Q1 2026 financial and operational highlights, including $594.3 million in cash, $36.5 million from warrant exercises, and 270 ounces of gold sold from small-scale mining at the Tintic Project. The Company resumed activities at the Cariboo Gold Project after a temporary suspension due to a fatal incident, and entered into a project management agreement with JDS Energy & Mining. Financing included a $143.8 million ...
05-11 21:49
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Catalyst Watch: Cerebras headlines AI-related IPO blitz, CPI print and 13Fs
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. Monday - May 11 Vo...
05-09 03:00
Barclays Maintains Underweight on Appian, Raises Price Target to $23
Barclays analyst Raimo Lenschow maintains Appian (NASDAQ:APPN) with a Underweight and raises the price target from $21 to $23.
05-08 22:37
Appian's AI Bet Pays Off: Q1 Beats Estimates, 2026 Profit Outlook Raised
Appian (APPN) stock edges higher after a Q1 earnings double-beat and a massive full-year profit hike. See how seven-figure auto deals and a surge in Agentic AI adoption are driving Appian's 21% revenue growth.
05-08 02:18
财报速睇 | Appian 2026财年Q1营收2.02亿美元，同比增长21.5%；归母净利润亏损0.02亿美元，同比亏损扩大29.6%
华盛资讯5月8日讯，Appian公布2026财年Q1业绩，公司Q1营收2.02亿美元，同比增长21.5%，归母净利润亏损0.02亿美元，同比亏损扩大29.6%。
05-08 01:17
财报速睇 | Appian 2026财年Q1营收2.02亿美元，同比增长21.7%；归母净利润亏损0.02亿美元，同比亏损扩大29.6%
华盛资讯5月7日讯，Appian公布2026财年Q1业绩，公司Q1营收2.02亿美元，同比增长21.7%，归母净利润亏损0.02亿美元，同比亏损扩大29.6%。
05-07 19:32
Appian Sees Q2 Adj EPS $(0.02)-$0.02 vs $0.10 Est; Sees Sales $191.000M-$195.000M vs $191.625M Est
Appian (NASDAQ:APPN) is looking for Q2 Adj EPS of $(0.02)-$0.02 vs $0.10 analyst estimate. sees sales of $191.000 million-$195.000 million vs $191.625 million analyst estimate.
05-07 19:13
